Paving the Way for Commercialization of Nanocrystal-Based LEDs

Evident Technologies, Inc. and Philips Electronics signed a non-exclusive licensing agreement paving the way for commercialization of nanocrystal-based LEDs. Evident Technologies intends to immediately launch a new line of low-power LED and LED based products that use semiconductor nanocrystals as a phosphor.

“LEDs last longer and are much more efficient than incandescent lights but are limited to only a few colors,” said Clint Ballinger, CEO of Evident Technologies. “We are excited about this licensing agreement and leveraging our technology to bring additional colors to these light sources.”

Light emitting diodes are fundamentally constrained to emit only a single color of light. The current state-of-the-art white LEDs use phosphors to convert blue LEDs into “white” or other colors. However, the underlying phosphor technology can limit the range of colors that are obtainable. Semiconductor nanocrystal technology removes these color limitations. Evident has been developing semiconductor nanocrystal technology for years and plans to immediately launch commercial LED products based on this technology.

“We have long believed that there is a market for semiconductor nanocrystal technology and we are looking forward to the technology being commercialized,” said Dave Barnes, Senior IP Council at Philips.

“The LED industry seems eager to embrace this technology,” said Dave Duncan, COO of Evident Technologies. “Our new line of LED products will enable us to enter the retail market as well, making them the world’s first consumer products based on semiconductor nanocrystals.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.